Search research articles
Contact Us
Filters
Showing results (1-10 of 98) with videos related to
Page
of 10
Sort By:
Biomedicines
|
December 24, 2021
NASH and Systemic Complications: From Basic to Clinical Research
Sabine Baumgartner, Ronit Shiri-Sverdlov
Biomedicines
|
February 13, 2020
NAFLD Preclinical Models: More than a Handful, Less of a Concern?
Yvonne Oligschlaeger, Ronit Shiri-Sverdlov
Expert Review of Gastroenterology & Hepatology
|
September 24, 2015
Cholesterol is a significant risk factor for non-alcoholic steatohepatitis
Sofie M A Walenbergh, Ronit Shiri-Sverdlov
Handbook of Experimental Pharmacology
|
March 19, 2020
Nonalcoholic Fatty Liver Disease
Lingling Ding, Yvonne Oligschlaeger, Ronit Shiri-Sverdlov, et al.
Cytokine & Growth Factor Reviews
|
December 4, 2014
MSP: an emerging player in metabolic syndrome
Jieyi Li, Dipanjan Chanda, Ronit Shiri-Sverdlov, et al.
Cells
|
July 17, 2020
<i>The Ins and Outs of Cathepsins</i>: Physiological Function and Role in Disease Management
Tulasi Yadati, Tom Houben, Albert Bitorina, et al.
Biochimica Et Biophysica Acta. Molecular and Cell Biology of Lipids
|
September 4, 2019
Low profile high value target: The role of OxLDL in cancer
Albert V Bitorina, Yvonne Oligschlaeger, Ronit Shiri-Sverdlov, et al.
Atherosclerosis
|
September 21, 2011
NASH and atherosclerosis are two aspects of a shared disease: central role for macrophages
Veerle Bieghs, Patrick C N Rensen, Marten H Hofker, et al.
Journal of Hepatology
|
November 28, 2012
Non-alcoholic steatohepatitis: the role of oxidized low-density lipoproteins
Sofie M A Walenbergh, Ger H Koek, Veerle Bieghs, et al.
Biomedicines
|
October 27, 2022
All Roads Lead to Cathepsins: The Role of Cathepsins in Non-Alcoholic Steatohepatitis-Induced Hepatocellular Carcinoma
Hester van Mourik, Mengying Li, Sabine Baumgartner, et al.
Page
of 10
Search research articles
Search
Showing results (1-10 of 98) with videos related to
Sort By:
Page
of 10
Biomedicines
|
December 24, 2021
NASH and Systemic Complications: From Basic to Clinical Research
Sabine Baumgartner, Ronit Shiri-Sverdlov
Biomedicines
|
February 13, 2020
NAFLD Preclinical Models: More than a Handful, Less of a Concern?
Yvonne Oligschlaeger, Ronit Shiri-Sverdlov
Expert Review of Gastroenterology & Hepatology
|
September 24, 2015
Cholesterol is a significant risk factor for non-alcoholic steatohepatitis
Sofie M A Walenbergh, Ronit Shiri-Sverdlov
Handbook of Experimental Pharmacology
|
March 19, 2020
Nonalcoholic Fatty Liver Disease
Lingling Ding, Yvonne Oligschlaeger, Ronit Shiri-Sverdlov, et al.
Cytokine & Growth Factor Reviews
|
December 4, 2014
MSP: an emerging player in metabolic syndrome
Jieyi Li, Dipanjan Chanda, Ronit Shiri-Sverdlov, et al.
Cells
|
July 17, 2020
<i>The Ins and Outs of Cathepsins</i>: Physiological Function and Role in Disease Management
Tulasi Yadati, Tom Houben, Albert Bitorina, et al.
Biochimica Et Biophysica Acta. Molecular and Cell Biology of Lipids
|
September 4, 2019
Low profile high value target: The role of OxLDL in cancer
Albert V Bitorina, Yvonne Oligschlaeger, Ronit Shiri-Sverdlov, et al.
Atherosclerosis
|
September 21, 2011
NASH and atherosclerosis are two aspects of a shared disease: central role for macrophages
Veerle Bieghs, Patrick C N Rensen, Marten H Hofker, et al.
Journal of Hepatology
|
November 28, 2012
Non-alcoholic steatohepatitis: the role of oxidized low-density lipoproteins
Sofie M A Walenbergh, Ger H Koek, Veerle Bieghs, et al.
Biomedicines
|
October 27, 2022
All Roads Lead to Cathepsins: The Role of Cathepsins in Non-Alcoholic Steatohepatitis-Induced Hepatocellular Carcinoma
Hester van Mourik, Mengying Li, Sabine Baumgartner, et al.
Page
of 10